Related references
Note: Only part of the references are listed.Predicting Therapeutic Antibody Delivery into Human Head and Neck Cancers
Guolan Lu et al.
CLINICAL CANCER RESEARCH (2020)
The Clinical Application of Fluorescence-Guided Surgery in Head and Neck Cancer
Stan van Keulen et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Current Challenges in Cancer Immunotherapy: Multimodal Approaches to Improve Efficacy and Patient Response Rates
Manpreet Sambi et al.
JOURNAL OF ONCOLOGY (2019)
Panitumumab-IRDye800CW for Fluorescence-Guided Surgical Resection of Colorectal Cancer
John C. Marston et al.
JOURNAL OF SURGICAL RESEARCH (2019)
Optical molecular imaging can differentiate metastatic from benign lymph nodes in head and neck cancer
Naoki Nishio et al.
NATURE COMMUNICATIONS (2019)
Roadmap for the Development and Clinical Translation of Optical Tracers Cetuximab-800CW and Trastuzumab-800CW
Matthijs D. Linssen et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs
Alyson Haslam et al.
JAMA NETWORK OPEN (2019)
The Effect of Fluorophore Conjugation on Antibody Affinity and the Photophysical Properties of Dyes
Agnes Szabo et al.
BIOPHYSICAL JOURNAL (2018)
Safety of panitumumab-IRDye800CW and cetuximab-IRDye800CW for fluorescence-guided surgical navigation in head and neck cancers
Rebecca W. Gao et al.
THERANOSTICS (2018)
Near-infrared Intraoperative Imaging of Thoracic Sympathetic Nerves: From Preclinical Study to Clinical Trial
Kunshan He et al.
THERANOSTICS (2018)
Zr-89-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer
Frederike Bensch et al.
NATURE MEDICINE (2018)
EGFR as a clinical marker in glioblastomas and other gliomas
Fadi S. Saadeh et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2018)
Tumor-Specific Uptake of Fluorescent Bevacizumab-IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility Study
Laetitia E. Lamberts et al.
CLINICAL CANCER RESEARCH (2017)
Regulatory Aspects of Optical Methods and Exogenous Targets for Cancer Detection
Willemieke S. Tummers et al.
CANCER RESEARCH (2017)
Development, preclinical safety, formulation, and stability of clinical grade bevacizumab-800CW, a new near infrared fluorescent imaging agent for first in human use
Eva J. ter Weele et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2016)
Development and Evaluation of a Fluorescent Antibody-Drug Conjugate for Molecular Imaging and Targeted Therapy of Pancreatic Cancer
Steve Knutson et al.
PLOS ONE (2016)
Safety and Tumor Specificity of Cetuximab-IRDye800 for Surgical Navigation in Head and Neck Cancer
Eben L. Rosenthal et al.
CLINICAL CANCER RESEARCH (2015)
IND-Directed Safety and Biodistribution Study of Intravenously Injected Cetuximab-IRDye800 in Cynomolgus Macaques
Kurt R. Zinn et al.
MOLECULAR IMAGING AND BIOLOGY (2015)
Protein aggregation and its impact on product quality
Christopher J. Roberts
CURRENT OPINION IN BIOTECHNOLOGY (2014)
Synthesis and biological evaluation of panitumumab-IRDye800 conjugate as a fluorescence imaging probe for EGFR-expressing cancers
Sibaprasad Bhattacharyya et al.
MEDCHEMCOMM (2014)
Fluorescently Labeled Therapeutic Antibodies for Detection of Microscopic Melanoma
Kristine E. Day et al.
LARYNGOSCOPE (2013)
Drug-Based Optical Agents: Infiltrating Clinics at Lower Risk
Werner Scheuer et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Aggregates in Monoclonal Antibody Manufacturing Processes
Maria Vazquez-Rey et al.
BIOTECHNOLOGY AND BIOENGINEERING (2011)
Assessment of Free Dye in Solutions of Dual-Labeled Antibody Conjugates for In Vivo Molecular Imaging
Melissa B. Aldrich et al.
MOLECULAR IMAGING AND BIOLOGY (2011)
Epidermal Growth Factor Receptor in Pancreatic Cancer
Melissa Oliveira-Cunha et al.
Cancers (2011)
Single-Dose Intravenous Toxicity Study of IRDye 800CW in Sprague-Dawley Rats
Milton V. Marshall et al.
MOLECULAR IMAGING AND BIOLOGY (2010)
Comparison of visible and near-infrared wavelength-excitable fluorescent dyes for molecular imaging of cancer
Kristen E. Adams et al.
JOURNAL OF BIOMEDICAL OPTICS (2007)
FDA drug approval summary: Panitumumab (Vectibix (TM))
Ruthann M. Giusti et al.
ONCOLOGIST (2007)
Epidermal growth factor receptor biology in head and neck cancer
Shailaja Kalyankrishna et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Effects of protein aggregates: An immunologic perspective
Amy S. Rosenberg
AAPS JOURNAL (2006)
Mechanisms of fluorescence quenching in donor-acceptor labeled antibody-antigen conjugates
U Schobel et al.
JOURNAL OF FLUORESCENCE (2000)
Share Paper
